导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.20% | 90/354 |
| 近一周 | -1.22% | 74/356 |
| 近一月 | -2.02% | 126/362 |
| 近一季 | 2.40% | 90/362 |
| 近半年 | 14.25% | 125/358 |
| 近一年 | 15.42% | 83/349 |
| 近两年 | 33.25% | 165/314 |
| 近三年 | 64.25% | 65/244 |
| 成立以来 | 179.57% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.14% 122/360 |
14.25% 106/366 |
- - |
- - |
| 2025 | 15.56% 224/358 |
-4.43% 217/340 |
10.13% 139/348 |
7.32% 220/354 |
2.29% 58/358 |
| 2024 | 20.85% 105/329 |
9.59% 42/280 |
3.47% 141/310 |
5.28% 154/318 |
1.24% 136/329 |
| 2023 | 23.31% 60/275 |
6.68% 59/205 |
7.93% 71/230 |
-3.13% 60/262 |
10.56% 82/276 |
| 2022 | -18.49% 82/201 |
-4.67% 31/153 |
-15.60% 118/164 |
-4.96% 65/189 |
6.59% 127/202 |
| 2021 | 26.14% 22/150 |
5.63% 62/312 |
7.83% 98/328 |
0.26% 85/358 |
10.46% 24/151 |
| 2020 | 14.45% 33/103 |
-20.16% 214/280 |
19.19% 104/295 |
8.15% 65/299 |
11.19% 107/305 |
| 2019 | 27.66% 27/88 |
12.52% 80/258 |
3.65% 64/267 |
1.12% 108/253 |
8.24% 101/266 |
| 2018 | -4.69% 30/79 |
- - |
- - |
6.52% 41/225 |
-12.34% 140/241 |
| 2017 | 16.22% 38/69 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 易方达标普500指数美元汇A VS. 建信富时100指数(QDII)人民币A(539003) |